Stocks›Healthcare
WatchAlert

Marksans Pharma Limited

MARKSANS · NSE · Healthcare · As of 8 Nov 2026
₹303.75
+₹0.05 (+0.02%)(1D)
₹155.0052 Week Range₹350.95
Market Cap
₹13,762 Cr
P/E (Sector)
24.6 (32.3)
P/B Ratio
4.55
Dividend Yield
0.30%
ROE
18.5%
Debt / Equity
0.10
Anvest Score
73/100
  • Valuation
    72
  • Quality
    69
  • Growth
    48
  • Health
    98
  • Momentum
    86

Fundamentals

P/E Ratio (TTM)
24.6
Sector median P/E
32.29
P/B Ratio
4.55
Sector median P/B
4.4
EPS (TTM)
₹12.35
Market Cap
₹13,762 Cr
Dividend Yield
0.3%
ROE
18.51%
ROCE
20.67%
Profit Margin
13.78%
Debt/Equity
0.1
Current Ratio
4.62
Interest Coverage
24.24
Book Value
₹66.72
Loading technical indicators…
Loading financial statement…
Loading shareholding…
Loading filings…

Marksans Pharma Limited FAQs

3 topics
Expand
What does the Marksans Pharma Limited (MARKSANS) stock page cover?
Marksans Pharma Limited on Anvest includes delayed price context, valuation ratios, a one-year price range, and section-level research data when available.
What are the current headline metrics for MARKSANS?
Marksans Pharma Limited is currently shown with a delayed price near ₹303.75, P/E 24.6, and ROE 18.51%.
Does the MARKSANS page provide investment advice?
No. The MARKSANS page is built for research, comparison, and planning. It does not publish buy, sell, or hold recommendations.
Keep exploring

Related insights